Bringing Med to MedTech - Physician, Scientist, Photographer, Traveler, Berliner, Immigrant 🇩🇪🇺🇸 - Views=My own, Like/RT≠Endorsement; Haemonetics employee
Brookline, MA
Joined August 2019
- Tweets1.9K
- Following202
- Followers300
- Likes1.6K
Age-Adjusted D-Dimer Cutoff in Suspected Deep Vein Thrombosis jamanetwork.com/journals/jam…
Like a Fine Wine—Aging the D-Dimer to Improve Value and Clinical Efficiency
Nice title for this editorial
jamanetwork.com/journals/jam…
Pre‐operative anaemia, red blood cell transfusion and mortality after cardiac surgery: a Netherlands Heart Registration mediation analysis - Groenewegen - Anaesthesia - Wiley Online Library associationofanaesthetists-p…
Our article on the trial of the HN cartridge for the TEG® 6s system featured in current issue of @_Anesthesiology.
A big thank you to our team of co‑authors, local PIs and their teams, and all the participating patients who made this possible. linkedin.com/posts/anesthesi…
TEG® 6s Heparin Neutralization Cartridge for Hemostatic... : Anesthesiology journals.lww.com/anesthesiol…
Football & Freunde 🇩🇪🇺🇸 — Germany Day at @Patriots Training Camp 2025.
@SebVollmer @themarkuskuhn @Fred_Kirsch @patsdeutsch
Jan Hartmann, MD retweeted
Coagulation factor XI is a promising target for safer anticoagulants. In a series of preclinical studies, novel factor XI-targeting GalNAc-siRNA RBD4059 showed high potency & long-lasting antithrombotic effects w/out ⬆️ 🩸 risk. jacc.org/doi/10.1016/j.jacbt…
#JACCBTS #CardioX #cvCoag
Last night at #ISTH2025, we honored a gentle giant—Dr. Hau Kwaan, Prof.em. at @NorthwesternMed. A true #Fibrinolysis pioneer with 400+ articles since the 1950s—still contributing posters in his 90s. Thanks, Mark Walsh, for a moving laudatio. linkedin.com/posts/janhartma…
Jan Hartmann, MD retweeted
Managing surgical bleeding is complex, but #viscoelastic testing is helping clinicians make more informed decisions. It can provide real-time insights and help guide targeted treatments to optimize perioperative and major bleeding management. ow.ly/B59z50VWH5z
This podcast episode with my favorite hematologist is a great resource for Sickle Cell Disease patients and their families and friends. #SCD podcasts.apple.com/us/podcas…
Emergent cardiac surgery, andexanet alfa–induced heparin resistance, a... sciencedirect.com/science/ar…
Please discuss. I will observe… 🍿 🍿 🍿
“Overall, there was little to no evidence of a difference between blood transfusion strategies for mortality or thromboembolic events.”
cochrane.org/CD012635/CENTRA…
Jan Hartmann, MD retweeted
Congratulations to Andrea Natale, MD, FHRS, winner of the 2025 Wilton Wells Webster Lectureship Award at #HRS2025. His lectureship was titled "Innovations in the Advancement of Care in Patients with AF in the Last 3 Decades: A Chronicle of My Journey." #EPeeps #LectureshipAward
Looking forward to this event in June. Press release here: newswire.com/news/german-ame…
Jan Hartmann, MD retweeted
In the SINGLE SHOT CHAMPION trial, pulsed field ablation was noninferior to cryoballoon ablation with respect to the incidence of a first recurrence of atrial tachyarrhythmia, as assessed by continuous rhythm monitoring.
Full trial results and Research Summary: nej.md/4iH5zQe
#Afib
ALT The New England Journal of Medicine Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation A Research Summary based on Reichlin T et al. | 10.1056/NEJMoa2502280 | Published on March 31, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
